McDermott Will & Schulte, a global law firm

Brian counsels public and private companies on various securities transactions, including initial public offerings (IPOs), issuer and third-party tender offers, private placements (including private investment in public equities (PIPEs)), registered direct offerings, and Rule 144A offerings of debt and convertible debt. He also handles matters involving Securities Exchange Act of 1934 compliance, venture capital, corporate governance, stock exchange listing, broker-dealer matters, and general corporate representation.

During law school, Brian was a judicial extern for the Honorable Jack B. Weinstein of the US District Court for the Eastern District of New York.

See Less

• Represented Inhibikase Therapeutics, Inc. (NASDAQ: IKT), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of cardiopulmonary and neurodegenerative disease through Abelson Tyrosine Kinase inhibition, in connection with a PIPE private placement of shares of common stock and warrants
• Represented Inhibikase Therapeutics, Inc. in a registered direct offering with an institutional investor to purchase shares of common stock (or pre-funded warrants in lieu thereof) and concurrent warrant inducement and private placement of warrants
• Represented Zura Bio Limited (NASDAQ: ZURA), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, in a private placement of Class A ordinary shares (or pre-funded warrants in lieu thereof)
• Represented Prime Healthcare Services, Inc., one of the largest acute care providers in the United States, in connection with the negotiation, documentation, and issuance of $1.5 billion of senior notes secured by certain real estate assets of Prime, the equity interests of Prime’s material subsidiaries, and certain other fixed assets, as well as in connection with a concurrent tender offer and consent solicitation to repurchase any and all of its outstanding senior secured notes due in 2025 and to amend the indenture governing the notes
• Represented Polished.com Inc. (NYSE: POL), an e-commerce platform for appliances, furniture, and home goods, in the structuring, negotiation, and documentation of an amendment to its existing credit facility
• Represented Zura Bio Limited in its business combination with JATT Acquisition Corp. (NYSE: JATT), a Cayman special purpose acquisition company (SPAC), and a concurrent private placement
• Represented CHW Acquisition Corporation, a SPAC, in its acquisition of Wag!, a pet care service platform
• Represented various sponsors and underwriters in SPAC formations and IPOs (NASDAQ and NYSE)
• Represented Enginuity Power Systems, a provider of clean technology solutions, in its first offering of Series A preferred shares
• Represented Viking Global Investors LP, a Connecticut-based investment firm, as the lead investor in the $200 million Series E funding at a valuation of $1.3 billion in Arctic Wolfe, a cybersecurity company
• Represented Shield AI Inc. in its acquisition of Heron Systems, Inc.*
• Represented Complex Networks in its sale by Verizon and Hearst to BuzzFeed for $300 million as part of BuzzFeed’s business combination with 890 5th Avenue Partners, Inc. (a SPAC)*
• Represented Tech Mahindra (NYSE: TECHM) in the acquisition of DigitalOnUs*

*Matter handled prior to joining the firm.

See Less